Francisco J. Marcos-Martinez
Huelva, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Campylobacter spp Bloodstream Infections in Immunocompetent vs Immunodeficient Patients: A Multinational Cohort Study (2009-2024).
Journal: Open forum infectious diseases
Published: March 05, 2026
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
Journal: Lancet (London, England)
Published: January 20, 2026
Safety and efficacy of convalescent plasma for COVID-19 in the pre-vaccine era, and implementation in a large healthcare system: A phase I/II randomized, multicentre clinical trial (PC-COVID).
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: November 24, 2025
Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections.
Journal: Antibiotics (Basel, Switzerland)
Published: October 07, 2025
How to use novel antimicrobials beyond official indications: an expert consensus.
Journal: JAC-antimicrobial resistance
Published: June 16, 2025
Identification and validation of clinical phenotypes in Staphylococcus aureus bloodstream infection and their association with mortality (FEN-AUREUS study).
Journal: EClinicalMedicine
Published: January 28, 2025
Severe invasive pulmonary aspergillosis caused by 2 different species of Aspergillus.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: September 24, 2024
Real-world evidence of dalbavancin effectiveness as consolidation therapy in infective endocarditis due to Enterococcus spp.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: May 11, 2024
Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
Journal: The Journal of antimicrobial chemotherapy
Published: April 26, 2024
Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data From the GAMES Series (2008-2021).
Journal: Open forum infectious diseases
Published: March 28, 2023
Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety.
Journal: Frontiers in pharmacology
Published: March 13, 2023
Last Updated: 09/26/2026